
Share
18th December 2021
07:00am GMT

This might feel like a setback for parents who have been hoping to have their younger kids vaccinated soon too, but Pfizer announced they will now continue their clinical trials, testing a three-dose vaccine regimen for kids in the 6 months to under 5-years-of age group. Rather than testing a higher dose of the vaccine in the 2 to 5 age group, the companies will seek approval for the three-dose regimen, with kids receiving a third shot at least two months after their second shot. Whether kids ages 5 to 11 need a third dose is also being investigated.Breaking News: Pfizer said its two-shot vaccine didn’t perform adequately in children 2 to 5, and it will test a three-dose series for official authorization. https://t.co/G8NhvNAhz8
— The New York Times (@nytimes) December 17, 2021
Explore more on these topics: